Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$2.0B
Avg Funding
$80.9M
Global Reach
6
countries

Top Cities for Biopharma

La Jolla
Copenhagen
Irvine
San Diego
Buffalo
Cambridge

Recently Funded Companies

Export
La Jolla, United States

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

$35.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark

Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.

$533K raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Irvine, United States

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

$125.0M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

Amplifica is a preclinical stage biopharmaceutical company focused on developing novel treatments to address androgenic alopecia.

$11.8M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Buffalo, United States

Cytocybernetics is a Biotechnology which specializes in cellular electrophysiology

$1.0M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Cambridge, United States

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

$550.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Lisbon, Portugal

Lxbio Pharmaceuticals is a Pharmaceutical company that develops biopharmaceutical products for the treatment of diabetic foot infections.

$6.6M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Santa Monica, United States

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

$13.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Wilmington, United States

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

$5.3M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Waltham, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

$719.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

New Haven, United States

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

$8.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Berkeley, United States

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

Mar 2025

Founder Contacts

30,000+ verified contacts

Stevenage, United Kingdom

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

$26.1M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

Monument Therapeutics used digital biomarkers to develop innovative new drugs for neuropsychiatric disorders including schizophrenia

Feb 2026

Founder Contacts

30,000+ verified contacts

Culver City, United States

NantBio offers treatments by developing molecularly targeted drugs, based on the molecular profile of the patient’s tumor.

$2.0M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Astrophysics technology for precision therapy through accurate modelling of biology

Feb 2024

Founder Contacts

30,000+ verified contacts

Friday Harbor, United States

Pattern Computer discovers valuable insights in complex data to transform business or research.

$1.8M raised
Feb 2022

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

$350.0M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Newyork, United Kingdom

Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases.

$7.0M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Columbus, United States

Andelyn Biosciences is a biopharmaceutical company that delivers treatments and therapies for patients.

$5.0M raised
Feb 2022

Founder Contacts

30,000+ verified contacts

Westlake Village, United States

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

$130.0M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Cork, Ireland

ArrayPatch is a biotech company that specializes in clinical development services.

$2.2M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.

$4.0M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Strasbourg, France

SUPERBRANCHE is a biotechnology company for the early detection and treatment of metastases through nanotechnological provisions.

$13.5M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Lyon, France

Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.

$4.6M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Showing 376 to 400 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$80.9M
Total Funding Tracked
$2.0B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Diego
2 companies$15.8M
2.Cambridge
2 companies$550.0M
3.London
2 companies$350.0M
4.La Jolla
1 companies$35.0M
5.Copenhagen
1 companies$533K

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 16 | VCBacked